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Background: Poor viability of engrafted stem cells hampers therapeutic efficacy for treatment of myocardial infarction (MI). This study is to 
investigate the role of Inositol phosphates 6 kinase (IP6Ks) for improving mesenchymal stem cells (MSCs) functional survival and cardiac protective 
effects after transplantation into infarcted mice hearts.
methods: and results:Bone marrow derived MSCs, isolated from dual-reporter firefly luciferase and enhanced GFP positive (Fluc+-eGFP+) 
transgenic mice, were preconditioned with IP6Ks inhibitor TNP (0.5μmol/L, 1μmol/L, 5μmol/L, 10μmol/L) for 2 h followed by 6 h of hypoxia and 
serum deprivation (H/SD) injury. TNP at 10μM significantly decreased IP7 production with increased Akt phosphorylation. Moreover, TNP (10μM) 
improved the viability and enhanced the paracrine effect of MSCs after H/SD. Furthermore, MSCs were transplanted into infarcted hearts with or 
without selective IP6Ks inhibition. Longitudinal bioluminescence imaging and immuno-staining revealed that TNP pretreatment enhanced survival 
of engrafted MSCs, which overtly promoted the anti-apoptotic and pro-angiogenic efficacy of MSCs in vivo. Furthermore, MSCs therapy with IP6Ks 
inhibition significantly decreased fibrosis and preserved heart function.
conclusion: Inhibition of IP6Ks promotes MSCs engraftment and paracrine effect in infarcted hearts by down-regulating IP7 production and 
enhancing Akt activation, which might attribute to preserved myocardial function after MI.
